NeuraMatrix

About:

NeuraMatrix is a biotechnology company engaged in developing implantable neural interfaces for neuroscience research and applications.

Website: http://www.neuramatrix.com.cn/

Top Investors: Matrix Partners China, Prosperity7 Ventures, Huagai Capital

Description:

NeuraMatrix is ​​a cutting-edge brain-computer interface technology developer. It uses cutting-edge question-computer interface technology to establish the ultimate way and platform for interactive human-computer information interaction, and realizes a one-stop service solution from hardware to software to digital devices. Influencing factors in brain science, neurological disease research, diagnosis and treatment, and innovating the new drug research and development evaluation system for neurological diseases, the wellhead is leveraging the enormous commercial application value of brain-computer interfaces. Recently completed 100 million yuan A round of financing, led by Huagai Capital, Saudi Aramco's diversified venture capital fund Prosperity7 Ventures, and old shareholder Jingwei China joined the investment. This round of financing will be mainly used for R&D equipment update, chip mass production, product iteration and market promotion.

Total Funding Amount:

100M CNY

Headquarters Location:

Beijing, Beijing, China

Founded Date:

2019-01-01

Contact Email:

contact(AT)neuramatrix.net

Founders:

Shuo Bai

Number of Employees:

1-10

Last Funding Date:

2021-11-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai